DNA News and Research

RSS

DNA, or deoxyribonucleic acid, is the hereditary material in humans and almost all other organisms. Nearly every cell in a person’s body has the same DNA. Most DNA is located in the cell nucleus (where it is called nuclear DNA), but a small amount of DNA can also be found in the mitochondria (where it is called mitochondrial DNA or mtDNA).

Sigma-Aldrich and Sangamo Biosciences extend license agreement for ZFP technology

Sigma-Aldrich Corporation and Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced a major expansion of their existing license agreement to include the exclusive rights to develop and distribute zinc finger DNA binding protein (ZFP)-modified cell lines for commercial production of protein pharmaceuticals.

5 Oct 2009

Inovio's SynCon H1N1 achieves protective antibody response against pandemic influenza in ferrets

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that a combination of its synthetic consensus (SynConTM) H1N1 influenza vaccine candidates achieved protective antibody responses against the novel pandemic influenza A/H1N1 (2009) in 100% of tested ferrets.

5 Oct 2009

Pharming announces EUR 20 million SEDA extension with YA Global

Biotech company Pharming Group NV ("Pharming" or "the Company") (NYSE Euronext: PHARM) today announces that it has extended its EUR 20 million Standby Equity Distribution Agreement (SEDA) with Yorkville Advisors Global Master SPV LTD ("YA Global") as announced on April 15, 2009, by an additional EUR 10 million to EUR 30 million in total.

5 Oct 2009

JCA-Mauvernay Award presented to Dr Toshikazu Ushijima for his research in oncology

Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, and the Japanese Cancer Association (JCA) presented 'The JCA-Mauvernay Award' to Dr Toshikazu Ushijima from the National Cancer Center Research Institute in Tokyo, for his outstanding and innovative research in basic science in the "epigenetic field for cancerization".

5 Oct 2009

Phase I clinical trial results to test the safety and immunogenicity of VGX-3100 released

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today interim safety and immunogenicity data from its therapeutic cervical cancer vaccine (VGX-3100) trial. VGX-3100 is a DNA vaccine targeting the E6 and E7 proteins of human papillomavirus (HPV) types 16 and 18 and is delivered via in vivo electroporation.

5 Oct 2009

Scientists uncover the role of first-responder molecule involved in repairing DNA strand breaks

Scientists from the U.S. Department of Energy's Lawrence Berkeley National Laboratory and the Scripps Research Institute have uncovered the role played by the least-understood part of a first-responder molecule that rushes in to bind and repair breaks in DNA strands, a process that helps people avoid cancer.

5 Oct 2009

Study identifies new genes associated with head and neck cancer

A Henry Ford Hospital study has identified 231 new genes associated with head and neck cancer, one of the most deadly cancers responsible for 2.1 percent of all cancer deaths in the United States.

5 Oct 2009

GeneMedRx software warns patients and physicians if tamoxifen benefit is at risk

One hundred eighty thousand women will be diagnosed with breast cancer this year. Eighty thousand will start taking the drug tamoxifen to prevent the recurrence of their ER (estrogen receptor) positive breast cancers. The treatment is successful in two-thirds of the women who take it. Genelex Corporation (Seattle) is now offering Tamoxitest(TM) that could improve this success rate to greater than 90% by addressing both of the common causes of tamoxifen treatment failure.

3 Oct 2009

Americans want to be better informed about developments in cutting-edge technologies

Nanotechnology and synthetic biology continue to develop as two of the most exciting areas of scientific discovery, but research has shown that the public is almost completely unaware of the science and its applications.

3 Oct 2009

Professor's research to transform mobile phones into powerful medical devices

Cell phones have come a long way in the last decade. Today, one can talk, text message, shoot photos and video, send and receive e-mail, and even access the Web. Now imagine a cell phone that can be used to monitor diseases like HIV or malaria and to test water quality after a major disaster like a hurricane or earthquake.

3 Oct 2009

NIMH awards USC scientists $9M for mapping gene expression during human brain development

Two University of Southern California (USC) neuroscientists have been awarded nearly $9 million in American Recovery and Reinvestment Act funds to map how genes are expressed in different regions of the human brain throughout development.

3 Oct 2009

CSIRO research on grains and lamb to develop new dietary sources of omega-3 oils

CSIRO research on grains and lamb aimed at developing new dietary sources of long-chain omega-3 oils will be presented at the World Congress on Oils and Fats in Sydney this week.

3 Oct 2009

Texas Health Presbyterian Hospital opens Hamon Tower for treating critically ill patients

Texas Health Presbyterian Hospital Dallas announces the opening of the Hamon Tower, the largest expansion in the hospital's history -- a medical complex devoted to intensive care for the region's most critically ill patients.

3 Oct 2009

61 institutions awarded grants for cancer research from American Cancer Society

The American Cancer Society, the largest non-government, not-for-profit funding source of cancer research in the United States, has awarded 94 new national research and training grants totaling $45,097,000 to 61 institutions nationwide in the second of two grants cycles for 2009. The grants go into effect beginning January 1, 2010.

3 Oct 2009

People with rare mutations of gene MUTYH at increased risk of bowel cancer

CANCER RESEARCH UK funded scientists have found that people who carry rare mutations within both copies of a gene called MUTYH are 28 times more likely to develop bowel cancer compared to the general population, according to a study in the Journal of Clinical Oncology.

1 Oct 2009

Epigentek Group releases SuperSense Methylated DNA Quantification kit

Epigentek Group Inc. today announced that it released the SuperSense(TM) Methylated DNA Quantification Kit to complete its line of methylated DNA quantification products. The SuperSense(TM) kit fluorometrically measures global DNA methylation shifts.

1 Oct 2009

Screening and diagnostic tests contribute to health care value across spectrum of care

Amidst ongoing debate in Congress over reforming the nation's health care system, a new report from the Lewin Group finds that screening and diagnostic laboratory tests are central to achieving some of the most important goals of health care reform.

1 Oct 2009

Presence of sequencing technologies in routine hospital and physician office labs over the next decade

As DNA testing expands and the price and speed of sequencing equipment improves, it's not out of the question that the half-million dollar sequencers now only available in top research labs may find their way into routine hospital and physician office labs throughout the U.S. over the next decade, according to the findings of Kalorama Information.

1 Oct 2009

Doris Duke Innovations award for sickle cell disease research

Sangamo BioSciences, Inc. announced today that research led by Donald B. Kohn, M.D., Professor of Microbiology, Immunology and Molecular Genetics (MIMG) and Pediatrics, the Director of the UCLA Human Gene Medicine Program and member of the Broad Stem Cell Research Center, and Philip Gregory, D. Phil., Sangamo's chief scientific officer and vice president, research, has been selected to receive a $486,000 Doris Duke Innovations in Clinical Research Award from the Doris Duke Charitable Foundation.

1 Oct 2009

Grand Opportunity grant to pursue "whole-genome" sequencing of patients with autism

Children's Hospital Boston, with the Broad Institute and Harvard Medical School, has been awarded a Grand Opportunity grant from the National Institute of Mental Health as part of the federal stimulus package, to pursue "whole-genome" sequencing of patients with autism, using new technologies for rapid DNA sequencing to better understand autism's causes.

1 Oct 2009

DNA News and Research

Further Reading

Sigma-Aldrich and Sangamo Biosciences extend license agreement for ZFP technology

Inovio's SynCon H1N1 achieves protective antibody response against pandemic influenza in ferrets

Pharming announces EUR 20 million SEDA extension with YA Global

JCA-Mauvernay Award presented to Dr Toshikazu Ushijima for his research in oncology

Phase I clinical trial results to test the safety and immunogenicity of VGX-3100 released

Scientists uncover the role of first-responder molecule involved in repairing DNA strand breaks

Study identifies new genes associated with head and neck cancer

GeneMedRx software warns patients and physicians if tamoxifen benefit is at risk

Americans want to be better informed about developments in cutting-edge technologies

Professor's research to transform mobile phones into powerful medical devices

NIMH awards USC scientists $9M for mapping gene expression during human brain development

CSIRO research on grains and lamb to develop new dietary sources of omega-3 oils

Texas Health Presbyterian Hospital opens Hamon Tower for treating critically ill patients

61 institutions awarded grants for cancer research from American Cancer Society

People with rare mutations of gene MUTYH at increased risk of bowel cancer

Epigentek Group releases SuperSense Methylated DNA Quantification kit

Screening and diagnostic tests contribute to health care value across spectrum of care

Presence of sequencing technologies in routine hospital and physician office labs over the next decade

Doris Duke Innovations award for sickle cell disease research

Grand Opportunity grant to pursue "whole-genome" sequencing of patients with autism

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest Life Science News